Investors dumped shares of drug distributor McKesson (MCK) after the company's earnings disappointed Wall Street. McKesson also cut its outlook, prompting a big selloff in other healthcare companies. TheStreet's Jim Cramer believes investors think the drug distribution group isn't needed, and future drug price increases will be limited. Other companies caught in the downdraft included Cardinal health (CAH) , CVS (CVS) , AbbVie (ABBV) , and AmerisourceBergen (ABC) . Jim Cramer says investors "are running like I've never seen." The selling in healthcare came even as the overall market rallied at midday.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.